These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 1646331

  • 1. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
    Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M, Brenneman DE.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):959-66. PubMed ID: 1646331
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors.
    Gozes I, Lilling G, Glazer R, Ticher A, Ashkenazi IE, Davidson A, Rubinraut S, Fridkin M, Brenneman DE.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):161-7. PubMed ID: 7714762
    [Abstract] [Full Text] [Related]

  • 4. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.
    Gozes Y, Brenneman DE, Fridkin M, Asofsky R, Gozes I.
    Brain Res; 1991 Feb 01; 540(1-2):319-21. PubMed ID: 1647246
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S, Kopras E, McMichael M, Bell RH, Ulrich CD.
    Cancer Res; 1997 Apr 15; 57(8):1475-80. PubMed ID: 9108448
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
    Zia H, Hida T, Jakowlew S, Birrer M, Gozes Y, Reubi JC, Fridkin M, Gozes I, Moody TW.
    Cancer Res; 1996 Aug 01; 56(15):3486-9. PubMed ID: 8758916
    [Abstract] [Full Text] [Related]

  • 12. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK, Barnett W, Coy DH, Tougas G, Daniel EE.
    J Pharmacol Exp Ther; 1991 Sep 01; 258(3):986-91. PubMed ID: 1653848
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S, Said SI.
    J Biol Chem; 1987 Jan 05; 262(1):158-62. PubMed ID: 3025200
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.